Healthcare provider profile · identity verified

Gerald Kane O'Bryan, M.D.

Internal Medicine · HOUMA, LA · NPI 1629259478

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	710	112
Atorvastatin Calcium	Atorvastatin Calcium	500	139
Gabapentin	Gabapentin	322	97
Pantoprazole Sodium	Pantoprazole Sodium	318	85
Amlodipine Besylate	Amlodipine Besylate	311	82
Furosemide	Furosemide	298	88
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	293	45
Alprazolam	Alprazolam	287	31
Losartan Potassium	Losartan Potassium	270	71
Ozempic	Semaglutide	259	39
Albuterol Sulfate Hfa	Albuterol Sulfate	241	63
Lisinopril	Lisinopril	209	58
Levothyroxine Sodium	Levothyroxine Sodium	205	50
Carvedilol	Carvedilol	204	62
Famotidine	Famotidine	201	62
Tamsulosin Hcl	Tamsulosin Hcl	173	49
Rosuvastatin Calcium	Rosuvastatin Calcium	169	55
Pregabalin	Pregabalin	165	48
Tramadol Hcl	Tramadol Hcl	154	37
Jardiance	Empagliflozin	150	43
Glimepiride	Glimepiride	145	33
Trazodone Hcl	Trazodone Hcl	142	43
Metformin Hcl	Metformin Hcl	137	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	134	37
Omeprazole	Omeprazole	132	35
Allopurinol	Allopurinol	129	41
Alendronate Sodium	Alendronate Sodium	128	34
Meloxicam	Meloxicam	128	40
Tizanidine Hcl	Tizanidine Hcl	127	33
Benazepril Hcl	Benazepril Hcl	124	31
Lovastatin	Lovastatin	122	32
Metformin Hcl Er	Metformin Hcl	122	28
Montelukast Sodium	Montelukast Sodium	121	35
Metoprolol Succinate	Metoprolol Succinate	120	37
Mounjaro	Tirzepatide	120	18
Pravastatin Sodium	Pravastatin Sodium	116	31
Hydrochlorothiazide	Hydrochlorothiazide	108	28
Duloxetine Hcl	Duloxetine Hcl	107	28
Fluticasone Propionate	Fluticasone Propionate	106	39
Clonazepam	Clonazepam	105	17
Spironolactone	Spironolactone	104	29
Clopidogrel	Clopidogrel Bisulfate	102	32
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	98	19
Azithromycin	Azithromycin	92	63
Ondansetron Odt	Ondansetron	87	37
Ibuprofen	Ibuprofen	85	26
Diazepam	Diazepam	81	13
Metoprolol Tartrate	Metoprolol Tartrate	80	21
Nifedipine Er	Nifedipine	78	20
Tradjenta	Linagliptin	76	21
Prednisone	Prednisone	73	51
Ezetimibe	Ezetimibe	72	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	16
Lorazepam	Lorazepam	69	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	24
Linzess	Linaclotide	66	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	11
Meclizine Hcl	Meclizine Hcl	62	14
Potassium Chloride	Potassium Chloride	60	21
Myrbetriq	Mirabegron	59	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	58	12
Amitriptyline Hcl	Amitriptyline Hcl	54	16
Doxazosin Mesylate	Doxazosin Mesylate	52	16
Escitalopram Oxalate	Escitalopram Oxalate	52	14
Zolpidem Tartrate	Zolpidem Tartrate	52	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	12
Finasteride	Finasteride	49	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	42
Dicyclomine Hcl	Dicyclomine Hcl	47	18
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	46	15
Simvastatin	Simvastatin	46	11
Mirtazapine	Mirtazapine	43	14
Diclofenac Sodium	Diclofenac Sodium	42	13
Oxybutynin Chloride Er	Oxybutynin Chloride	42	12
Eliquis	Apixaban	41	14
Hydroxyzine Hcl	Hydroxyzine Hcl	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	11
Fluconazole	Fluconazole	39	18
Bupropion Xl	Bupropion Hcl	37	suppressed
Ventolin Hfa	Albuterol Sulfate	37	13
Latanoprost	Latanoprost	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	29
Methocarbamol	Methocarbamol	33	11
Nortriptyline Hcl	Nortriptyline Hcl	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Atenolol	Atenolol	31	suppressed
Clindamycin Hcl	Clindamycin Hcl	31	23
Glipizide	Glipizide	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	11
Trulicity	Dulaglutide	30	suppressed
Baclofen	Baclofen	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Nitroglycerin	Nitroglycerin	28	13
Novolog Flexpen	Insulin Aspart	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Cilostazol	Cilostazol	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	15
Januvia	Sitagliptin Phosphate	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Valsartan	Valsartan	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	14
Ketoconazole	Ketoconazole	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Sumatriptan	Sumatriptan	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Mupirocin	Mupirocin	20	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	19	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Praluent Pen	Alirocumab	19	suppressed
Risperidone	Risperidone	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Lacosamide	Lacosamide	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Amoxicillin	Amoxicillin	17	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Nystatin	Nystatin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Naproxen	Naproxen	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Colchicine	Colchicine	13	11
Doxycycline Monohydrate	Doxycycline Monohydrate	13	13
Fentanyl	Fentanyl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Triazolam	Triazolam	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Sulindac	Sulindac	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error